hippuryl-histidyl-leucine has been researched along with bradykinin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiwada, K; Kokubu, T; Nishimura, K; Ueda, E; Yoshida, N | 1 |
| Brooks, RR; Burns, RH; Huang, CT; Jones, SM; Miller, KE | 1 |
| Bara, AT; Busse, R; Hecker, M; Pörsti, I | 1 |
| Bara, AT; Busse, R; Hecker, M | 1 |
| Andrade, MC; Boim, MA; Carmona, AK; Casarini, DE; Quinto, BM; Ribas, OS; Schor, N | 1 |
| de Bruin, RJ; Deinum, J; Dive, V; Hectors, M; Jan Danser, AH; Montgomery, HE; Payne, JR; van Esch, JH; van Gool, JM | 1 |
6 other study(ies) available for hippuryl-histidyl-leucine and bradykinin
| Article | Year |
|---|---|
Purification of angiotensin I-converting enzyme from human lung.
Topics: Angiotensin II; Bradykinin; Chromatography; Hippurates; Humans; Hydrogen-Ion Concentration; Kinetics; Lung; Molecular Weight; Oligopeptides; Peptidyl-Dipeptidase A; Trypsin | 1977 |
Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Guinea Pigs; Hydrolysis; In Vitro Techniques; Male; Muscle Contraction; Oligopeptides; Peptidyl-Dipeptidase A; Substrate Specificity | 1990 |
Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Vessels; Epoprostenol; Female; In Vitro Techniques; Isoquinolines; Jugular Veins; Male; Oligopeptides; Prostaglandin Endoperoxides, Synthetic; Rabbits; Ramipril; Receptors, Bradykinin; Tetrahydroisoquinolines; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 1994 |
Potentiation of the biological efficacy of bradykinin by ACE inhibitors: a shift in the affinity of the B2 receptor?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Drug Synergism; In Vitro Techniques; Isoquinolines; Jugular Veins; Oligopeptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Rabbits; Ramipril; Rats; Receptor, Bradykinin B2; Receptors, Bradykinin; Tetrahydroisoquinolines; Vasoconstriction | 1996 |
Purification and characterization of angiotensin I-converting enzymes from mesangial cells in culture.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Cattle; Cells, Cultured; Chlorides; Chromatography, Gel; Enalaprilat; Glomerular Mesangium; Hydrogen-Ion Concentration; In Vitro Techniques; Isoenzymes; Molecular Weight; Oligopeptides; Peptidyl-Dipeptidase A; Rats; Substrate Specificity; Temperature | 1998 |
Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype.
Topics: Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Vessels; Enzyme Activation; Female; Genotype; Humans; In Vitro Techniques; Male; Middle Aged; Oligopeptides; Peptidyl-Dipeptidase A; Phosphinic Acids; Point Mutation; Protein Structure, Tertiary; Sus scrofa; Tetrahydroisoquinolines; Vasoconstrictor Agents; Vasodilator Agents | 2008 |